Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility is currently unavailable.

Search Results Details (942)

SortShow
Name Institution Why
Jean J. Zhao, Ph.D.Dana-Farber Cancer Institute Why?
Thomas McCoy Roberts, Ph.D.Dana-Farber Cancer Institute Why?
Shuji Ogino, Ph.D., M.D.Brigham and Women's Hospital Why?
C. Ronald Kahn, M.D.Joslin Diabetes Center Why?
Jennifer Ruth Brown, Ph.D., M.D.Dana-Farber Cancer Institute Why?
Alex Toker, Ph.D.Beth Israel Deaconess Medical Center Why?
Stefano Gianni, M.D.Massachusetts General Hospital Why?
Reza Abdi, M.D.Brigham and Women's Hospital Why?
David Marc Weinstock, M.D.Dana-Farber Cancer Institute Why?
Franziska M. Ippen, M.D.Massachusetts General Hospital Why?
John M Asara, Ph.D.Beth Israel Deaconess Medical Center Why?
Ian Elliott Krop, M.D.,Ph.D.Dana-Farber Cancer Institute Why?
Daniel P. Cahill, M.D.,Ph.D.Massachusetts General Hospital Why?
Jaclyn LoPiccolo, Ph.D., M.D.Dana-Farber Cancer Institute Why?
Jamil Azzi, M.D.Brigham and Women's Hospital Why?
Per Page    Page  of 63last Nextnext
Prev
Search Criteria
  • Class I Phosphatidylinositol 3 Kinases
Click "Why?" to see why a person matched the search.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.